AlphaCentric Advisors’s InflaRx IFRX Stock Holding History

AlphaCentric Advisors’s Portfolio IFRX Stock Details IFRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-3,000	Closed	-$13K	–	217
2020 Q3	$13K	Buy	+3,000	New	+$13.8K	0.01%	152

Other funds holding IFRX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Bank Julius Baer & Co Zurich, Switzerland $33.2B AUM 25.01% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

SFI

Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return

AlphaCentric Advisors's IFRX Position: Q4 2020 in Review

AlphaCentric Advisors sold out of InflaRx (IFRX) in Q4 2020, closing a stake of 3,000 shares — an estimated $13K sold.

AlphaCentric Advisors first reported a position in IFRX in Q3 2020 and held it in 1 quarter. The position peaked at $13K in Q3 2020. 33 funds tracked by Wall St. Rank hold IFRX as of Q4 2020.

AlphaCentric Advisors reported no remaining InflaRx position as of Q4 2020 after selling out during the quarter.
AlphaCentric Advisors sold 3,000 InflaRx shares in Q4 2020, an estimated $13K.
AlphaCentric Advisors first reported a position in InflaRx in Q3 2020 and held it in 1 quarter.
AlphaCentric Advisors's InflaRx position peaked at $13K in Q3 2020.
33 funds tracked by Wall St. Rank held InflaRx as of Q4 2020.

Based on AlphaCentric Advisors's 13F filing for Q4 2020, filed 11 Mar 2022.